Home Infusion Therapy Market Scope And Analysis

Home Infusion Therapy Market Report Scope

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global home infusion therapy market are listed below:

1. In January 2023, Eitan Medical announced the opening of its new manufacturing facility at the company’s headquarters. On-site manufacturing will support Eitan Medical’s production scale of its Pharmaceutical Solutions division. The facility will manufacture the Sorrel wearable drug delivery platform across multiple device configurations, including Sorrel vial- and cartridge-based wearable injectors, pre-filled and pre-loaded in primary containers up to 50ml, as well as small volume on-body injectors.
2. In May 2022, Fresenius Kabi completed the acquisition of Ivenix, a manufacturer of infusion systems. Fresenius Kabi now offers health care professionals in the United States a broad and expanding portfolio of advanced infusion pumps and solutions to meet needs across the continuum of care.
3. In January 2022, ICU Medical Inc announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion.
4. In June 2021, Micrel Medical Devices announced the expansion of their global presence with the announcement of a new distribution partnership with Baxter in Australia and New Zealand for the Rythmic PN+, ambulatory Infusion pump for Home Parenteral Nutrition.
5. In June 2021, Micrel Medical and Baxter Healthcare (Baxter) announced an agreement for the distribution of the Micrel Mini Rythmic PN+ infusion pump for Parenteral Nutrition (PN). Micrel Mini Rythmic PN+ is an ambulatory infusion pump supporting patients with Hospital-in-the-Home Parenteral Nutrition. As part of the agreement, Baxter Healthcare will be the sole distributor of the Micrel Mini Rythmic PN+ infusion pump and its accessories across ANZ.

Competitive Landscape and Key Companies:

There are various prominent players operating in the global home infusion therapy market. Some top home infusion companies are B. Braun Melsungen AG, Micrel Medical Devices SA, Baxter International Inc, Nipro Corp, Becton Dickinson and Co, Fresenius Kabi AG, ICU Medical Inc, JMS Co Ltd, Eitan Medical Ltd, and Terumo Corp, among others. These companies focus on various new product developments and geographical expansions. This helps them to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence which allows them to serve a large set of customers. Also, it offers opportunity to increase their market share.